Relationship between the Nature of Mucus and Crypt Multiplicity in Aberrant Crypt Foci in the Rat Colon

Aberrant crypt foci (ACF)induced in the distal colon of F344 male rats, 4, 8, 12 and 35 weeks after the first administration of 1, 2‐dimethylhydrazine‐2HCl (DMH) were examined to determine whether a correlation exists between the nature of goblet cell mucin and the number of crypts (crypt multiplicity) comprising the ACF. According to the ACF score calculated from the results of the qualitative observation of sulfomucins (SuMs) and sialomucins (SiMs), the ACF in the 4th week showed a weak correlation between the nature of the mucus and crypt multiplicity, and the ACF of each class showed similar mucous profiles. From the 8th week, a significant difference (P<0.01) was recognized between the ACF consisting of 3 crypts or less and those consisting of 4 crypts or more. The proportion of crypts with SiM predominance showed a decrease in the 8th.week in the ACF consisting of 1 crypt and in the 12th week in the ACF consisting of 2 or 3 crypts, implying a recovery tendency. The ACF consisting of more than 4 crypts showed little change over time, retaining the tendency of SiM predominance. Ulex europaeus agglutinin‐I (UEA‐I) lectin‐positive crypts appeared in the ACF. This finding was significantly more prominent (P< 0.001) in the ACF with SiM predominance than in the ACF with SuM predominance at each experimental period, and in the 12th week after the first administration of DMH, the incidence of ACF with UEA‐I‐reactive mucin was decreased in the ACF groups consisting of 3 crypts or less, compared with the ACF groups consisting of 4 or more crypts.These results suggest that the biological quality of mucus in ACF consisting of 4 or more crypts is different from that in ACF consisting of 3 crypts or less. This difference should be considered when ACF are used as an intermediate biomarker of colon cancer.

[1]  E. Kristiansen.  The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice. , 1996, Cancer letters.

[2]  T. Irimura,et al.  Expression of Sulfomucins in Normal Mucosae, Colorectal Adenocarcinomas and Metastases , 1995, Japanese journal of cancer research : Gann.

[3]  A. Biggeri,et al.  Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. , 1995, British Journal of Cancer.

[4]  T. Ishikawa,et al.  DNA adduct formation and assessment of aberrant crypt foci in vivo in the rat colon mucosa after treatment with N-methyl-N-nitrosourea. , 1994, Carcinogenesis.

[5]  B. Magnuson,et al.  Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. , 1993, Cancer research.

[6]  S. Carraro,et al.  Ulex europeus agglutinin I binding pattern during chemical carcinogenesis in the rat gastrointestinal tract , 1993, Cancer.

[7]  T. Sugimura,et al.  Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid. , 1993, Cancer research.

[8]  J. R. Jass,et al.  Ulex Europaeus Agglutinin‐1 Binding In Hereditary Bowel Cancer , 1993, Pathology.

[9]  T. P. Pretlow,et al.  Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. , 1992, Carcinogenesis.

[10]  L. Lam,et al.  Reduction of aberrant crypt formation in the colon of CF1 mice by potential chemopreventive agents. , 1991, Carcinogenesis.

[11]  R. Bird,et al.  Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci. , 1991, Carcinogenesis.

[12]  I. Zusman,et al.  Role of morphological methods in the analysis of chemically induced colon cancer in rats. , 1991, Acta anatomica.

[13]  T. P. Pretlow,et al.  Enzyme-altered foci in colons of carcinogen-treated rats. , 1990, Cancer research.

[14]  E. Riecken,et al.  Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine‐induced colonic carcinogenesis , 1988, European journal of clinical investigation.

[15]  R. Bird,et al.  Specificity study to evaluate induction of aberrant crypts in murine colons. , 1988, Cancer research.

[16]  R P Bird,et al.  Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.

[17]  S. Yonezawa,et al.  LECTIN HISTOCHEMISTRY IN A CASE OF ULCERATIVE COLITIS COMPLICATING RECTAL CARCINOMA , 1985, Acta pathologica japonica.

[18]  T Nakamura,et al.  Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel. , 1982, Journal of the National Cancer Institute.

[19]  S. Barthold,et al.  Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. , 1977, Cancer research.

[20]  M. I. Filipe,et al.  Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study. , 1975, British Journal of Cancer.

[21]  M. Filipe.  Value of histochemical reactions for mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum. , 1969, Gut.

[22]  S. Spicer.  DIAMINE METHODS FOR DIFFERENTIATING MUCOSUBSTANCES HISTOCHEMICALLY , 1965 .